Abstract : Magnetite needle, in which magnetite particles are molded into needle-shape, was developed and we applied it as a heating mediator for intracellular hyperthermia. We investigated the hyperthermic effect on solid subcutaneous gliomas in the femoral region of female F344 rats. Magnetite needles were inserted into the solid tumors, which were then irradiated by an alternating magnetic field (118 kHz, 384 Oe). The rats were divided into a control group that was not irradiated (control group), or a group that was irradiated for 30 min three times (treatment group), then we evaluated the hyperthermic effect on tumor growth. Tumors completely regressed in 75% of the treated rats. Histological observations showed that magnetite particles in the control group were localized only around the point of the tumor where the needle was inserted. However, the particles in the treatment group were widespread, and necrotic cells were observed throughout almost the entire tumor tissue. The magnetite particles were flowed away by blood flow as the tumor regressed, and so the needles did not require removal from the femoral region. Moreover, the administration of two magnetite needles required only three minutes, although the magnetite cationic liposomes were injected over at least 120 min to prevent backflow.
Introduction
Hyperthermia using heating mediators is a promising approach to uniform heating of only tumor areas to a desired temperature without invasing normal tissue 1) 2). Inductive heating methods have been investigated that use sub-micron magnetic particles as heating mediators [3] [4] [5] For injection into tumors, the magnetite needle is inserted through a syringe and catheter.
Photographs are before (A) and after (B) assembly.
Preparation of specimens for histological observation
Tumors were removed 24 h after needle insertion or after three exposures to hyperthermia. Blood was replaced with phosphate buffer, then the tumor was extracted, fixed with 10% formalin, and longitudinally sectioned. Pathological specimens were cut into sections of 6 mm thickness, and stained with hematoxylin and eosin.
Animal experiments proceeded according to the "Guide for the Care and Use of Laboratory Animals" prepared under the directions of the Office of the Prime Minister of Japan.
Results
Temperature increase by magnetite needles in alternating magnetic field
We measured the temperature at the outside of the tumor by use of the inserted magnetite needles.
The hyperthermic effect at the peripheral area of the tumor would be weaker than that at the inside of the tumor. Fig. 2 Fig. 3 . shows the time courses of tumor growth in each group. The tumor volume in the control rats steadily increased with no evidence of regression. In contrast, tumors completely regressed in many of the exposed rats. In most instances of complete regression, the tumor volume continued to increase in the first five days, then began to decrease and finally disappeared. Tumors did not reappear after complete regression for over a period of 3 months (data not shown).
The data from Fig. 3 are summarized in Table I . The incidence of complete tumor regression in the treated rats was 75%. The rats were also weighed for 90 days. The gains of rats with completely regressed glioma tumors were similar to those of control rats without tumors (data not shown), and severe removed by the blood flow around the tumor. In fact, 3.5 mg/ml of MCLs could not heat 0.1 ml of brain tumor in a mouse since blood flow in the brain is much faster than that in subcutaneous tumors in the femoral area. When the diameter of the affected region is halved at the same concentration of the mediator, heat evolution per volume drops to 1/8, but heat transfer via the surface of the affected area drops to only 1/4. Therefore, concentrated magnetite solution should be administrated to double the concentration in the tumor. Compared with DM and MCLs, our heat mediator can be prepared at a higher concentration (1.83 grams of magnetite per mlliliter), which means that more magnetite can be delivered to the tumor tissue. The present study used two pieces of the magnetite needles to heat tumors.
The total quantity of magnetite particles was 11.5 mg, which generated a very high temperature, since this amount of particles correspond to 1.6 ml of MCLs. This is an advantage of the needle-type magnetite heating mediators since injecting 1.6 ml of the MCLs into 1 ml of tumor is obviously difficult.
To inject 1.6 ml of MCLs into a tumor, the time required would be at least two hours since backflow should be prevented. On the other hand, two magnetite needles were easily inserted within 3 min without inducing the cerebral pressure changes by liquid injections. This presents another advantage of magnetite needles in a clinical therapeutic environment.
Many needle-type heating mediators such as ferromagnetic tumor implants have been proposed 1)2) 9) 10) Prediction of the temperature distribution by means of computer simulation is not hard if the blood flow rate around the tumor tissue is known. However, these protocols have some downsides, such as accidental shifting in the affected part or troublesome removal from the body. The magnetite needles proposed here are made of magnetite particles with about 25 nm and carboxymethyl cellulose. As binding ability of carboxymethyl cellulose is not so strong, the magnetite needles became individual magnetite particles where they were inserted in tissues, and dispersed gradually in tissues after repeated heatings. As described above, the profile of temperature increase in the second or third exposure was similar to that during the first exposure to magnetic field. Therefore, sufficient magnetite particles that can heat tumor still remained before the third exposure. We found here that the magnetite needles or particles disappeared completely after tumors had regressed. They may be eventually flowed away by blood flow or removed by phagocytic cells. In this way, it is not necessary to remove the magnetite needles after therapeutic treatment. This is not a feature of the conventional needle-type heat mediators and is therefore the third advantage of magnetite needles. The magnetite particles removed from the tumor tissue were deposited in liver, but they were disappeared from liver within a month. We could not detect the magnetite in other organs except spleen, but almost magnetites were also disappeared from spleen after a month. No severe side effects such as unusual behavior or hematuria were observed.
We used CMC as the bulking agent for the magnetite needles. Water-soluble CMC has no known toxicity and is widely used in drugs and foods. Oligosaccharides, polysaccharides, collagen or gelatin should also be effective as a CMC substitute.
Conclusion
Our new magnetite needles were used to treat solid tumors by hyperthermia in vivo. The tumor tissue completely disappeared in many rats exposed to a magnetic field, and the needles were simply administered through a syringe. The magnetite needle will be a novel and potentially effective mediator of hyperthermia that can be used to treat other malignant solid tumors without severe side effects. 
